Abstract
This project aims at developing and evaluating functionalized vesicular nanocarriers for the intraductal administration of a combination of cytotoxic drugs for treatment of localized forms of breast cancer, integrating greater selectivity and efficacy. It is justified by the gaps in the current breast cancer management strategies, including treatment of the non-invasive forms, such as int…